DermBiont raises $35.2M Series B to advance two topical skin drugs through PhIInews2023-10-25T10:51:18+00:00October 25th, 2023|Endpoints News|
Grifols Alzheimer’s vaccine appears safe, but efficacy unclear, in PhII studynews2023-10-24T22:31:05+00:00October 24th, 2023|Endpoints News|
FDA expected to decide on AstraZeneca’s self-administered flu vaccine next quarternews2023-10-24T19:13:37+00:00October 24th, 2023|Endpoints News|
Samsung adds another Lucentis interchangeable biosimilar to the mixnews2023-10-24T19:07:11+00:00October 24th, 2023|Endpoints News|
Biogen, GSK, Novo Nordisk named in Time’s best inventions of 2023 listnews2023-10-24T18:49:05+00:00October 24th, 2023|Endpoints News|
Form 483 for UCB’s Swiss site notes deficiencies in quality control operationsnews2023-10-24T18:42:27+00:00October 24th, 2023|Endpoints News|
Amgen to cut 350 staffers following $28B Horizon takeovernews2023-10-24T18:25:47+00:00October 24th, 2023|Endpoints News|
Sanders goes after NIH for granting exclusive patent for potential cancer therapynews2023-10-24T16:58:01+00:00October 24th, 2023|Endpoints News|
Merck KGaA raises awareness for smoldering MS symptoms that cause patients to ‘unravel’news2023-10-24T16:45:17+00:00October 24th, 2023|Endpoints News|
How Novo Nordisk’s Rybelsus went from pandemic washout to blockbuster amid the GLP-1 boomnews2023-10-24T16:41:23+00:00October 24th, 2023|Endpoints News|
